Efficacy of vaginal danazol treatment in women with menorrhagia during fertile age

Fertility and Sterility

Volumn 92, Issue 4, 2009, Pages 1351-1354

  Luisi, Stefano ^a   Razzi, Sandro ^a   Lazzeri, Lucia ^a   Bocchi, Caterina ^a   Severi, Filiberto M ^a   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

anemia; danazol; fertile age; Menorrhagia; ovarian cycle

Indexed keywords

DANAZOL; ESTRADIOL; FOLLITROPIN; HEMOGLOBIN; LIOTHYRONINE; LUTEINIZING HORMONE; PROLACTIN; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BLEEDING; BLOOD CELL COUNT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ERYTHROCYTE COUNT; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; FREE THYROXINE INDEX; HEMATOCRIT; HUMAN; HYSTEROSCOPY; LIOTHYRONINE BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUAL CYCLE; MENSTRUATION; PATIENT SATISFACTION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRANSVAGINAL ECHOGRAPHY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

ADMINISTRATION, INTRAVAGINAL; ADULT; AGE FACTORS; DANAZOL; ERYTHROCYTE COUNT; ESTROGEN ANTAGONISTS; FEMALE; FERTILITY; HEMATOCRIT; HEMOGLOBINS; HUMANS; MENORRHAGIA; PATIENT SATISFACTION; TREATMENT OUTCOME;

EID: 70349448606     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.08.017     Document Type: Article

References (17)

1. Mohan S., Page L.M., and Higham J.M. Diagnosis of abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol 21 (2007) 891-903
2. Bachmann G., and Korner P. Bleeding patterns associated with oral contraceptive use: a review of the literature. Contraception 76 (2007) 182-189
3. Robins J.C. Therapies for the treatment of abnormal uterine bleeding. Curr Womens Health Rep 1 (2001) 196-201
4. Koh S.C., and Singh K. The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia. J Thromb Haemost 5 (2007) 133-138
5. Beaumont H., Augood C., Duckitt K., and Lethaby A. Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev 3 (2007) CD001017
6. Chimbira T.H., Anderson A.B., Naish C., Cope E., and Turnbull A.C. Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo. Br J Obstet Gynaecol 87 (1980) 1152-1158
7. Dockeray C.J., Sheppard B.L., and Bonnar J. Comparison between mefenamic acid and danazol in the treatment of established menorrhagia. Br J Obstet Gynaecol 96 (1989) 840-844
8. Higham J.M., and Shaw R.W. A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia. Am J Obstet Gynecol 169 (1993) 1134-1139
9. Nafarelin European Endometriosis Trial Group (NEET). Nafarelin for endometriosis: A large scale, danazol-controlled trial of efficacy and safety, with 1-year follow up. Fertil Steril 57 (1992) 514-522
10. Mais V., Cossu E., Angioni S., Piras B., Floris L., and Melis G.B. Abnormal uterine bleeding: medical treatment with vaginal danazol and five-year follow-up. J Am Assoc Gynecol Laparosc 11 (2004) 340-343
11. Guerriero S., Paoletti A.M., Ajossa S., et al. Influence of vaginal danazol on uterine and brain perfusion during hormonal replacement therapy. Menopause 8 (2001) 424-428
12. Razzi S., Luisi S., Calonaci F., Altomare A., Bocchi C., and Petraglia F. Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis. Fertil Steril 88 (2007) 789-794
13. Larroy C. Comparing visual analog and numeric scales for assessing menstrual pain. Behav Med 27 (2002) 179-181
14. Cobellis L., Razzi S., Fava A., Severi F.M., Igarashi M., and Petraglia F. A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis. Fertil Steril 82 (2004) 239-240
15. Mizutani T., Nishiyama S., Amakawa I., Watanabe A., Nakamuro K., and Terada N. Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository. Fertil Steril 63 (1995) 1184-1189
16. Telimaa S., Apter D., Reinila M., Ronnberg L., and Kauppila A. Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate. Eur J Obstet Gynaecol Reprod Biol 36 (1990) 97-105
17. Ledford M.R., Horton A., Wang G., Brito M., and Delgado L. Efficacy of danazol in a patient with congenital protein-S deficiency: paradoxical evidence for decreased platelet activation with increased thrombin generation. Thromb Res 87 (1997) 473-482